Anthracycline analogs The past, present, and future
- 1 December 1986
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 18 (3), 185-197
- https://doi.org/10.1007/bf00273384
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1985
- Phase II study of epirubicin in advanced adenocarcinoma of the pancreasEuropean Journal of Cancer and Clinical Oncology, 1985
- Absence of generation of oxygen-containing free radicals with 4′-deoxydoxorubicin, a non-cardiotoxic anthracycline drugBiochemical and Biophysical Research Communications, 1984
- Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicinEuropean Journal of Cancer and Clinical Oncology, 1984
- Intensely potent morpholinyl anthracyclinesJournal of Medicinal Chemistry, 1984
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984
- Clinical phase I trial of marcellomycin with a single-dose scheduleEuropean Journal of Cancer and Clinical Oncology, 1983
- Antitumor activity in mice of 4′-Deoxydoxorubicin in comparison with doxorubicinEuropean Journal of Cancer and Clinical Oncology, 1983
- Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracile and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (bcnu). Comparison with doxorubicin derivatives: 4′deoxydoxorubicin and 4′-0-methyldoxorubicinInternational Journal of Cancer, 1981
- Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinoneJournal of Medicinal Chemistry, 1975